Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL2200 vs Aspirin for GI Safety in At-Risk Subjects
NCT01646814Phase 2Completed
- Sponsor
- PLx Pharma Inc.
- Start
- Sep 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pl-2200 in gastroduodenal ulceration, sponsored by PLx Pharma Inc.. Started Sep 2012; status: completed.
02
Drugs
pl-2200
03
Conditions
gastroduodenal ulceration
Beyond the preview
Go deeper on NCT01646814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01646814.